Predictors and outcomes of intracranial hemorrhage in 58,000 patients with atrial fibrillation on oral anticoagulation: insights from COMBINE-AF

2 September 2024 (08:15 - 08:27)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Manasi Tannu

Duke Clinical Research Institute, Durham (United States of America)

4 More presentations in this session

Presentation thumbnail

Anticoagulation and stroke in hospitalized patients newly diagnosed with secondary atrial fibrillation: a population-based cohort study

Doctor H. Abdel-Qadir (Toronto, CA)

Abstract Slides Video

Presentation thumbnail

Post-operative atrial fibrillation during cardiac rehabilitation: incidence and long-term prognostic value.

Doctor S. Rastelli (IT)

Abstract Slides Video

Presentation thumbnail

Use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation across five stages of chronic kidney diseases

Doctor T. Chao (Taipei, TW)

Abstract Slides Video

Presentation thumbnail

Risk of thromboembolic and haemorrhagic events associated with anticoagulation among 11,355 patients with non-valvular atrial fibrillation and thrombocytopenia

Doctor M. Tam (Shatin, HK)

Abstract Slides Video

Access the full session

Session thumbnail

Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations

The Event

Event poster

ESC Congress 2024

2 September 2024 08:15 CET

You may be interested in

Congress Session

Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations

Congress Presentation

Resumption of anticoagulation therapy among Non-Valvular Atrial Fibrillation (NVAF) patients with prior intracranial haemorrhage

Congress Session

The bleeding brain: cardiologists and cerebral haemorrhage

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources